BioCentury
ARTICLE | Clinical News

MatriStem MicroMatrix: Phase IV started

January 27, 2014 8:00 AM UTC

ACell began a single-blind, U.S. Phase IV trial to compare standard of care (SOC) plus MatriStem MicroMatrix particles or MatriStem Wound Matrix sheets vs. SOC plus Dermagraft in about 102 patients w...